Could a cancer drug unlock language in kids with autism?

NCT ID NCT02839915

First seen May 11, 2026 · Last updated May 13, 2026 · Updated 1 time

Summary

This study looks at whether folinic acid (leucovorin), a drug already used to reduce side effects from chemotherapy, can improve language skills in children with autism spectrum disorder. About 56 children aged 5 to 17 will take the drug for 12 to 24 weeks, and researchers will measure changes in their language abilities using standard tests. The goal is to see if this treatment can ease language problems, not cure autism.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AUTISM SPECTRUM DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Children's Healtcare of Atlanta

    Atlanta, Georgia, 30322, United States

  • Harvard University

    Lexington, Massachusetts, 02421, United States

  • Southwestern Research and Resource Center

    Phoenix, Arizona, 85016, United States

  • State University of New York, Downstate

    Brooklyn, New York, 11203, United States

Conditions

Explore the condition pages connected to this study.